Another case of PML hits the MS drug Tysabri
PML is a rare demylinating disease that occurs in 6 per 10 million patients. This is the third case that is associated with Tysabri. Investors are not happy.
Subscribe to KevinMD and never miss a story!
Get free updates delivered free to your inbox.







![A leader's journey through profound grief and loss [PODCAST]](https://kevinmd.com/wp-content/uploads/The-Podcast-by-KevinMD-WideScreen-3000-px-4-190x100.jpg)




![How genetic testing redefines motherhood [PODCAST]](https://kevinmd.com/wp-content/uploads/Design-3-190x100.jpg)